Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000116857 | SCV000168055 | benign | not specified | 2016-11-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001079523 | SCV000287211 | benign | Neuronal ceroid lipofuscinosis | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000116857 | SCV000339182 | benign | not specified | 2016-01-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000625068 | SCV000369561 | likely benign | Neuronal ceroid lipofuscinosis 10 | 2018-02-13 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Center for Pediatric Genomic Medicine, |
RCV000431476 | SCV000511690 | likely benign | not provided | 2016-09-22 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Athena Diagnostics Inc | RCV000116857 | SCV000613029 | benign | not specified | 2017-01-24 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000625068 | SCV000743667 | benign | Neuronal ceroid lipofuscinosis 10 | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313875 | SCV000847637 | benign | Inborn genetic diseases | 2017-01-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000625068 | SCV002802254 | likely benign | Neuronal ceroid lipofuscinosis 10 | 2021-08-12 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000116857 | SCV000150931 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Genome Diagnostics Laboratory, |
RCV000625068 | SCV000745773 | likely benign | Neuronal ceroid lipofuscinosis 10 | 2017-02-20 | no assertion criteria provided | clinical testing |